Ascendis Pharma A/S (ASND) has 8 open-market insider trades by 5 insiders since 2026. Over the last six months insiders net sold $4.7M. The most active filer is Jean Jacques Bienaime, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Flemming Steen Jensen | — | — | 1 | $4.6M | 2026-05-11 |
| Mads Bodenhoff | VP | — | 1 | $811K | 2026-09-08 |
| Jean Jacques Bienaime | Dir | — | 3 | $699K | 2026-08-14 |
| Scott Thomas Smith | CFOVP | — | 2 | $78K | 2026-06-02 |
| Lars Holtug | Dir | — | 1 | $62K | 2026-09-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mads Bodenhoff | VP | Sell | $811K | 2026-09-08 |
| Lars Holtug | Director | Sell | $62K | 2026-09-02 |
| Jean Jacques Bienaime | Director | Buy | $493K | 2026-08-14 |
| Scott Thomas Smith | CFO & VP | Buy | $22K | 2026-06-02 |
| Scott Thomas Smith | CFO & VP | Buy | $56K | 2026-05-29 |
| Jean Jacques Bienaime | Director | Buy | $112K | 2026-05-29 |
Companies that share insiders with ASND, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jean Jacques Bienaime | Director | Buy | $95K | 2026-05-26 |
| Flemming Steen Jensen | — | Sell | $4.6M | 2026-05-11 |